RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Risks and Benefits of Conducting Preclinical Studies in the Global Setting

Risks and Benefits of Conducting Preclinical Studies in the Global Setting

Posted 01 December 2011 | By Mukesh KumarJanice Longstreth

It is generally accepted that the preclinical studies needed for first-in-man clinical studies usually take one to three years and cost up to $10 million USD, and the preclinical studies needed for market approval application cost about $70-$90 million.1

 

© 2022 Regulatory Affairs Professionals Society.